Skip to main content
. 2021 Jan 28;10:621435. doi: 10.3389/fonc.2020.621435

Figure 2.

Figure 2

Distribution of FR+CTC level in lung adenocarcinoma patients with different subtypes. Low Risk Group (n = 23) including patients with adenocarcinoma in situ, minimally invasive adenocarcinoma and invasive adenocarcinoma predominantly showing lepidic or acinar growth pattern. High Risk Group (n = 13) including patients with invasive mucinous adenocarcinoma and invasive adenocarcinoma predominantly showing micropapillary or solid growth pattern.